The conference location is not yet confirmed. The conference will take place in Spain but the city is still to be decided. Malaga has been used to indicate Spain, but this city is not final yet.
The conference will address new trends in vaccine development and life cycle management, including (1) use of platform technologies, (2) prior knowledge, (3) development of novel vaccines comprising therapeutic vaccines and cancer vaccines, and (4) considerations on accelerated development scenarios. In this context, Quality by Design principles have now been embedded in various aspects of vaccine development and beyond. The conference will provide an overview of the applicability of QbD in various aspects, from product, analytics and process standpoint and considerations during life cycle management, as well as touch base on newer trends in the regulatory field such as ICHQ12.
© Copyright 2008-2019 Semigator GmbH | Für die Richtigkeit der Angaben übernehmen wir keine Gewähr.